Mihai Ghilezan

1.1k total citations
14 papers, 866 citations indexed

About

Mihai Ghilezan is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Cancer Research. According to data from OpenAlex, Mihai Ghilezan has authored 14 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Radiation and 5 papers in Cancer Research. Recurrent topics in Mihai Ghilezan's work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Advanced Radiotherapy Techniques (7 papers). Mihai Ghilezan is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Advanced Radiotherapy Techniques (7 papers). Mihai Ghilezan collaborates with scholars based in United States, Australia and United Kingdom. Mihai Ghilezan's co-authors include Frank A. Vicini, Hong Ye, Daniel Krauss, Gary Gustafson, Alvaro A. Martinez, Larry L. Kestin, Chirag Shah, D. Jeffrey Demanes, Yoshiya Yamada and Gil’ad N. Cohen and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology and American Journal of Clinical Oncology.

In The Last Decade

Mihai Ghilezan

14 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mihai Ghilezan United States	11	564	443	189	151	125	14	866
Gyoergy Kovács Germany	8	413 0.7×	285 0.6×	109 0.6×	102 0.7×	63 0.5×	13	570
Raxa Sankreacha Canada	13	405 0.7×	471 1.1×	127 0.7×	164 1.1×	168 1.3×	27	699
Tom Budiharto Belgium	15	1.0k 1.8×	477 1.1×	174 0.9×	184 1.2×	475 3.8×	30	1.3k
Bradley J. Stish United States	14	513 0.9×	183 0.4×	62 0.3×	138 0.9×	159 1.3×	66	700
Alison Grann United States	11	380 0.7×	187 0.4×	159 0.8×	454 3.0×	108 0.9×	23	891
Måns Agrup Sweden	5	589 1.0×	422 1.0×	57 0.3×	83 0.5×	193 1.5×	15	759
Larry B. Levy United States	12	1.0k 1.8×	441 1.0×	44 0.2×	176 1.2×	112 0.9×	15	1.2k
Razvan Galalae Germany	17	583 1.0×	436 1.0×	44 0.2×	178 1.2×	126 1.0×	43	873
Mary Ann Lockett United States	13	314 0.6×	139 0.3×	86 0.5×	342 2.3×	91 0.7×	14	811
C.A. Mantz United States	13	390 0.7×	232 0.5×	59 0.3×	146 1.0×	125 1.0×	61	679

Countries citing papers authored by Mihai Ghilezan

Since Specialization

Citations

This map shows the geographic impact of Mihai Ghilezan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihai Ghilezan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihai Ghilezan more than expected).

Fields of papers citing papers by Mihai Ghilezan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mihai Ghilezan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihai Ghilezan. The network helps show where Mihai Ghilezan may publish in the future.

Co-authorship network of co-authors of Mihai Ghilezan

This figure shows the co-authorship network connecting the top 25 collaborators of Mihai Ghilezan. A scholar is included among the top collaborators of Mihai Ghilezan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mihai Ghilezan. Mihai Ghilezan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Martinez, Alvaro A., Chirag Shah, Nasiruddin Mohammed, et al.. (2015). Ten-year outcomes for prostate cancer patients with Gleason 8 through 10 treated with external beam radiation and high-dose-rate brachytherapy boost in the PSA era. Journal of Radiation Oncology. 5(1). 87–93. 1 indexed citations

Yamada, Yoshiya, Leland Rogers, D. Jeffrey Demanes, et al.. (2012). American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy. 11(1). 20–32. 233 indexed citations

Korman, Howard, Thomas Lanni, Chirag Shah, et al.. (2012). Impact of a Prostate Multidisciplinary Clinic Program on Patient Treatment Decisions and on Adherence to NCCN Guidelines. American Journal of Clinical Oncology. 36(2). 121–125. 51 indexed citations

Shah, Chirag, Thomas Lanni, Mihai Ghilezan, et al.. (2012). Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer. Brachytherapy. 11(6). 441–445. 85 indexed citations

Martinez, Alvaro A., Jose A. Gonzalez, Hong Ye, et al.. (2011). Dose Escalation Improves Cancer-Related Events at 10 Years for Intermediate- and High-Risk Prostate Cancer Patients Treated With Hypofractionated High-Dose-Rate Boost and External Beam Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 79(2). 363–370. 126 indexed citations

Wilkinson, J. Ben, Alvaro A. Martinez, Peter Y. Chen, et al.. (2011). Four-year results using balloon-based brachytherapy to deliver accelerated partial breast irradiation with a 2-day dose fractionation schedule. Brachytherapy. 11(2). 97–104. 21 indexed citations

Vicini, Frank A., Chirag Shah, Larry L. Kestin, et al.. (2011). Identifying Differences Between Biochemical Failure and Cure: Incidence Rates and Predictors. International Journal of Radiation Oncology*Biology*Physics. 81(4). e369–e375. 6 indexed citations

Shah, Chirag, Michelle Wallace, Larry L. Kestin, et al.. (2011). Differences in Disease Presentation, Treatment Outcomes, and Toxicities in African American Patients Treated With Radiation Therapy for Prostate Cancer. American Journal of Clinical Oncology. 35(6). 566–571. 9 indexed citations

Shah, Chirag, Mihai Ghilezan, Douglas W. Arthur, et al.. (2011). Initial clinical experience with multilumen brachytherapy catheters for accelerated partial breast irradiation. Brachytherapy. 11(5). 369–373. 14 indexed citations

10.

Shah, Chirag, J. Ben Wilkinson, Mihai Ghilezan, et al.. (2011). Factors Associated With the Development of Breast Cancer–Related Lymphedema After Whole-Breast Irradiation. International Journal of Radiation Oncology*Biology*Physics. 83(4). 1095–1100. 41 indexed citations

11.

Huang, Jiayi, Frank A. Vicini, Scott Williams, et al.. (2011). Percentage of Positive Biopsy Cores: A Better Risk Stratification Model for Prostate Cancer?. International Journal of Radiation Oncology*Biology*Physics. 83(4). 1141–1148. 45 indexed citations

12.

Shah, Chirag, J. Vito Antonucci, J. Ben Wilkinson, et al.. (2011). Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: Results of a matched-pair analysis. Radiotherapy and Oncology. 100(2). 210–214. 94 indexed citations

13.

Mohammed, Nasiruddin, Larry L. Kestin, Mihai Ghilezan, et al.. (2010). Comparison of Acute and Late Toxicities for Three Modern High-Dose Radiation Treatment Techniques for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 82(1). 204–212. 117 indexed citations

14.

Wallace, Michelle, Alvaro A. Martinez, Christina Mitchell, et al.. (2009). Phase I/II Study Evaluating Early Tolerance in Breast Cancer Patients Undergoing Accelerated Partial Breast Irradiation Treated With the MammoSite Balloon Breast Brachytherapy Catheter Using a 2-Day Dose Schedule. International Journal of Radiation Oncology*Biology*Physics. 77(2). 531–536. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact